The 1 May 2015 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. The Schedule includes the following new/revised entries:

• Leuprorelin acetate (Lucrin Depot Paediatric) - new indication
• Mesalazine (Salofalk) - new strength

For more details, go to: http://www.pbs.gov.au/browse/changes